01:46 PM EDT, 05/30/2024 (MT Newswires) -- (Updates with the latest stock movement in the headline and first paragraph.)

Avita Medical ( RCEL ) shares were up more than 10% in recent Thursday trading after the company said it has received the US Food and Drug Administration's premarket approval supplement for its cell harvesting device, Recell Go, for the treatment of thermal burn wounds and partial and full-thickness defects.

The regenerative medicine company said it plans to launch Recell Go at US burn centers in June, with existing accounts transitioning throughout the year and new accounts to receive Recell Go from the start.

Price: 9.75, Change: +0.94, Percent Change: +10.67